Title: A rational approach to the regioselective deacetylation of 2',3',5'-tri-O-acetyluridine by Novozym 435 catalysed alcoholysis.
Journal: Biochimica et biophysica acta 20120401
Title: Use of uridine triacetate for the management of fluorouracil overdose.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111001
Title: Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement.
Journal: PloS one 20110101
Title: Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients.
Journal: Experimental and clinical psychopharmacology 20080601
Title: Phthalocyanine-based molecularly imprinted polymers as nucleoside receptors.
Journal: Metal-based drugs 20080101
Title: Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease.
Journal: Neurobiology of disease 20061201
Title: Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
Journal: Investigational new drugs 20061101
Title: 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Journal: Cancer chemotherapy and pharmacology 20060701
Title: Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases.
Journal: Diseases of the colon and rectum 20060301
Title: Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
Journal: Brain research 20051220
Title: Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity.
Journal: Neuromolecular medicine 20040101
Title: Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.
Journal: Brain research 20031219
Title: Synthesis and hypnotic activities of 4-thio analogues of N3-substituted uridines.
Journal: Chemical & pharmaceutical bulletin 20010901
Title: Ma WW, et al. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity. Cancer. 2017 Jan 1;123(2):345-356.
Title: Cada DJ, et al. Uridine Triacetate. Hosp Pharm. 2016 Jun;51(6):484-8.
Title: Rolando A G Garcia, et al. Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency. Toxicol Appl Pharmacol. 2018 Aug 15;353:67-73.
Title: Siennah R Miller, et al. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling. Mol Pharmacol. 2021 Feb;99(2):147-162.
